Century Therapeutics (IPSC) Intangibles (2021 - 2026)

Century Therapeutics (IPSC) has 4 years of Intangibles data on file, last reported at $34.2 million in Q1 2026.

• Intangibles for Q1 2026 came in at $34.2 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.2 million (changed 0.0% YoY), and the FY2025 annual result was $34.2 million, changed 0.0% from the prior year.
• Intangibles was little changed at $34.2 million in Q1 2026 per IPSC's latest filing, from $34.2 million in the prior quarter.
• Over five years, Intangibles peaked at $34.2 million in Q4 2024 and troughed at $33.3 million in Q2 2024.
• A 3-year average of $34.0 million and a median of $34.2 million in 2024 frame the typical range for Intangibles.
• On a YoY basis, Intangibles climbed as much as 2.7% in 2025 and fell as far as 0.0% in 2025.
• A 3-year view of Intangibles shows it stood at $34.2 million in 2024, then changed by 0.0% to $34.2 million in 2025, then changed by 0.0% to $34.2 million in 2026.
• Business Quant data shows IPSC's Intangibles at $34.2 million in Q1 2026, $34.2 million in Q4 2025, and $34.2 million in Q3 2025.